Switch to:

Xarelto will be a preferred drug on Medicare Advantage formulary

Switch to:
Switch to:

Search

Popular Tasks

Contact Us

Visit a ConnectiCare Center

Xarelto will be a preferred drug on Medicare Advantage formulary

06/08/2018

Xarelto® will be listed as a preferred drug under our Medicare Advantage formulary for the treatment and prevention of blood clots, effective June 1.

provider

Language Assistance:

©2022 ConnectiCare. All Rights Reserved.

Any information provided on this Website is for informational purposes only. It is not medical advice and should not be substituted for regular consultation with your health care provider. If you have any concerns about your health, please contact your health care provider's office. Also, this information is not intended to imply that services or treatments described in the information are covered benefits under your plan. Please refer to your Membership Agreement, Certificate of Coverage, Benefit Summary, or other plan documents for specific information about your benefits coverage.